Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Sell
7,978
-220
-3% -$30.4K 0.47% 57
2026
Q2
$1.05M Sell
8,198
-113
-1% -$13.2K 0.41% 65
2026
Q1
$1000K Sell
8,311
-50
-0.6% -$5.77K 0.42% 63
2025
Q4
$880K Sell
8,361
-699
-8% -$65.6K 0.34% 67
2025
Q3
$760K Hold
9,060
– – 0.28% 71
2025
Q2
$717K Hold
9,060
– – 0.28% 72
2025
Q1
$813K Hold
9,060
– – 0.22% 66
2024
Q4
$891K Buy
+9,060
New +$934K 0.25% 64

Other funds holding MRK

InvesTrust's MRK Position: Q3 2026 in Review

InvesTrust reduced its Merck (MRK) stake by 2.7% in Q3 2026, selling an estimated $30.4K and leaving 7,978 shares worth $1.16M. The position accounts for 0.47% of the portfolio, ranked #57.

InvesTrust first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 1,906 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • InvesTrust held 7,978 shares of Merck worth $1.16M as of Q3 2026.
  • InvesTrust sold 220 Merck shares in Q3 2026, an estimated $30.4K.
  • Merck made up 0.47% of InvesTrust's portfolio in Q3 2026, its #57 holding.
  • InvesTrust first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 1,906 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on InvesTrust's 13F filing for Q3 2026, filed 14 Oct 2026.